Condensed Consolidated Statement of Changes in Stockholders' Equity (Deficit) (Unaudited) - 9 months ended Sep. 30, 2016 - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance (in shares) at Dec. 31, 2015	8,118,939
Balance at Dec. 31, 2015	$ 8,119	$ 42,102,876	$ (42,152,618)	$ (41,623)
Fair value of RestorGenex shares (in shares)	1,861,503			1,861,503
Fair value of RestorGenex shares	$ 1,862	19,544,138		$ 19,546,000
Estimated fair value of RestorGenex stock options outstanding		1,321,000		1,321,000
Estimated fair value of RestorGenex warrants outstanding		384,000		$ 384,000
Stock Issued During Period, Shares, Issued for Services	148,073			45,643
Stock Issued During Period, Value, Issued for Services	$ 148	1,409,215		$ 1,409,363
Conversion of convertible debt (in shares)	217,122			217,122
Conversion of convertible debt	$ 217	711,278		$ 711,495
Settlement of litigation matter upon issuance of convertible debt		2,500,000		2,500,000
Stock-based compensation expense		1,121,990		1,121,990
Net loss			(15,465,912)	(15,465,912)
Balance (in shares) at Sep. 30, 2016	10,345,637
Balance at Sep. 30, 2016	$ 10,346	$ 69,094,497	$ (57,618,530)	$ 11,486,313